Results 51 to 60 of about 883,247 (168)
The carbohydrate antigen (CA 19-9) is a marker for pancreatic and colorectal carcinoma. In our study, we have investigated the level of CA 19-9 at 50 patients with benign and malign disease using three immunoassays.The COBAS e 601 (Roche) uses an ECLIA, Architect i2000 analyzer (Abbott) uses CMIA and VITROS 5600 uses integrated System Intellicheck ...
openaire +3 more sources
Isolated CA 19-9 Elevation as Preceding Finding of Colorectal Carcinoma
Rectal bleeding, change in bowel habits, abdominal pain are cardinal symptoms of colorectal carcinoma. Otherwise, weight loss, fatigue and weakness do not suggest colorectal carcinoma.
Abdurrahman Sahin +3 more
doaj +1 more source
Mucin-producing urothelial-type adenocarcinoma of the prostate (MPUAP) is a rare, aggressive neoplasm thought to originate from the prostatic urethral urothelium.
Keisuke Nonaka +10 more
doaj +1 more source
Introduction The association of Heated Tobacco Products (HTPs) use on cancerrelated biomarkers remains unclear. This study aimed to compare the levels of tumor markers, specifically alpha-fetoprotein (AFP), carbohydrate antigen 19-9 (CA 19-9 ...
Dae-Hyun Kim, Seung-Wan Hong, Naeun Park
doaj +1 more source
Intrapericardial bronchogenic cyst with marked production of antigen CA 19-9; a case report.
症例は33歳女性, 前胸部痛, 咳嗽, を主訴に当院受診.画像診断にて右前縦隔に心臓を前方より圧迫する10cm程の嚢胞を認めた.末梢血のCA19-9は12,531U/mlと高値を示しており, 嚢胞内液のCA19-9は240万U/ml以上と異常高値を示していた.手術所見では嚢胞は心嚢内に進展していたが直接浸潤は認めなかった.病理所見では嚢胞壁は多列繊毛上皮に覆われ気管支腺, 軟骨, 平滑筋, 肺組織も認められた.術後CA19-9は低下し正常化した.気管支性嚢胞は縦隔内のいたるところに発生するが, 心嚢内に進展した症例はきわめて稀である.また嚢胞内液のCA19-9が本例のような異常高値を呈した症例は報告が無い.
Shinichi Matsuge +2 more
openaire +2 more sources
INTRODUCTION: To hasten management and improve patients’ quality of life, there is a need for quick, cheap and accessible biomarkers of breast cancer prognosis following confirmatory diagnosis.
Ganiyu Olatunbosun Arinola +3 more
doaj +1 more source
Tumor marker carbohydrate antigen 19-9 (CA 19-9) level has gained clinical significance in gastrointestinal malignancies and in various solid and cystic diseases.
Reza Khorramirouz +3 more
doaj +1 more source
[Carbohydrate antigens CA 19-9, CA 242, CA 50 in liver diseases].
Serum concentrations of CA 19-9, CA 242, and CA 50 were determined in patients with hepatitis and liver cirrhosis without cholestasis. The study included 63 patients with chronic persistent hepatitis (group A), chronic active hepatitis (group B), and liver cirrhosis (group C).
J, Nowak +8 more
openaire +1 more source
Background Carbohydrate antigen (CA) 19-9 is used as a clinical tumor marker of pancreatic cancer; recent studies report that CA 19-9 is also associated with changes in blood glucose levels.
Masanori Shimodaira MD, PhD +5 more
doaj +1 more source
The immunohistochemical expression of CA19-9, epithelial membrane antigen (EMA), and carcinoembryonic antigen (CEA) was studied in 103 tissue samples of gallbladder cancer and 25 samples of non tumoral gallbladder lesions. CA19-9 and EMA were positive in over 90% of cancers and non tumoral lesions. Dupan-2 expression was observed in 100% of non tumoral
I, Roa +6 more
openaire +1 more source

